Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Synovitis, Pigmented Villonodular × emactuzumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Synovitis, Pigmented Villonodular 1 Synovitis 1 Solid Cancers 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Fallopian Tube Neoplasms 1 Brenner Tumor 1 Advanced Solid Tumors 1

Interventions

pexidartinib 3 nilotinib 2 emactuzumab 1 cabiralizumab 1 Tolbutamide 1 Midazolam 1 Bro protein, Drosophila 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05417789 2026-02-02

TANGENT

SynOx Therapeutics Limited

Phase 3 Active not recruiting

Synovitis, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡